HeMo Bioengineering this week announced that it received pre-market approval in China for its aspiration catheter. The Afentta intracranial thrombectomy aspiration catheter is a direct aspiration treatment option for acute ischemic stroke thrombectomy and has demonstrated lower post-stroke treatment disability rates and disease burden in … [Read more...] about HeMo Bioengineering aspiration catheter wins pre-market approval in China
